Brexpiprazole versus placebo or other antidepressive agents for treating depression
Journal article
Ralovska S. et al, (2023), Cochrane Database of Systematic Reviews, 2023
The indirect relationship between sleep and cognition in the PREVENT Cohort: Identifying targets for intervention
Preprint
Tari B. et al, (2023)
Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife.
Journal article
Dounavi M-E. et al, (2023), J Cereb Blood Flow Metab
Insulin resistance, age and depression’s impact on cognition in middle-aged adults from the PREVENT cohort
Journal article
Bauermeister SD. et al, (2023), BMJ Mental Health, 26, e300665 - e300665
Insulin Resistance's Impact on Cognition in Middle Aged Adults from the PREVENT cohort: Interactive Effects with Depression
Preprint
Bauermeister S. et al, (2023)
Barriers to brain health behaviours: results from the Five Lives Brain Health Ireland Survey.
Journal article
Dukelow T. et al, (2023), Front Psychol, 14
Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
Journal article
Muurling M. et al, (2023), PLoS One, 18
Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.
Journal article
Koychev I. et al, (2023), PLoS One, 18
Neurodegenerative disease of the brain: a survey of interdisciplinary approaches
Journal article
Davenport F. et al, (2023), Journal of the Royal Society, Interface, 20
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
Journal article
Low A. et al, (2022), Alzheimers Res Ther, 14
Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
Journal article
Dounavi M-E. et al, (2022), J Neurol, 269, 4299 - 4309
Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model.
Journal article
Liu Q. et al, (2022), BMC Med, 20
Modifiable risk factors for dementia, and awareness of brain health behaviors: Results from the Five Lives Brain Health Ireland Survey (FLBHIS).
Journal article
Dukelow T. et al, (2022), Front Psychol, 13
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.
Journal article
Ng B. et al, (2022), Brain Commun, 4
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
Journal article
Sen A. et al, (2021), Trials, 22
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A Double-Blind, Placebo Controlled, Randomised Cross Over Proof of Concept Study
Journal article
Sen A. et al, (2021)
Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives.
Journal article
Rogers JP. et al, (2021), J Neurol Neurosurg Psychiatry
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis
Journal article
Badenoch J. et al, (2021)
Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.
Journal article
Muurling M. et al, (2021), Alzheimers Res Ther, 13